The DOI matches its Crossref record.
A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacology
Abstract
OBJECTIVES: An increasing body of evidence indicates that Pycnogenol (PYC), a standardized extract of French maritime pine bark, has favorable pharmacological properties. This is a review of studies with both PYC and components of the preparation, that have helped to elucidate target sites and possible mechanisms for activity in men. METHODS: Studies appearing in peer reviewed literature, as well as results presented at international meetings not yet available as published papers, are included in this review. Additional data from published sources in German and French languages that are not widely available are also included. RESULTS: Chemical identification studies showed that PYC is primarily composed of procyanidins and phenolic acids. Procyanidins are biopolymers of catechin and epicatechin subunits which are recognized as important constituents in human nutrition. PYC contains a wide variety of procyanidins that range from the monomeric catechin and taxifolin to oligomers with 7 or more flavonoid subunits. The phenolic acids are derivatives of benzoic and cinnamic acids. The ferulic acid and taxifolin components are rapidly absorbed and excreted as glucuronides or sulphates in men, whereas procyanidins are absorbed slowly and metabolized to valerolactones which are excreted as glucuronides. PYC has low acute and chronic toxicity with mild unwanted effects occurring in a small percentage of patients following oral administration. Clinical studies indicate that PYC is effective in the treatment of chronic venous insufficiency and retinal micro-hemorrhages. PYC protects against oxidative stress in several cell systems by doubling the intracellular synthesis of anti-oxidative enzymes and by acting as a potent scavenger of free radicals. Other anti-oxidant effects involve a role in the regeneration and protection of vitamin C and E. Anti-inflammatory activity has been demonstrated in vitro and in vivo in animals. Protection against UV-radiation-induced erythema was found in a clinical study following oral intake of PYC. In asthma patients symptom scores and circulating leukotrienes are reduced and lung function is improved. Immunomodulation has been observed in both animal models as well as in patients with Lupus erythematosus. PYC antagonizes the vasoconstriction caused by epinephrine and norepinephrine by increasing the activity of endothelial nitric oxide synthase. Dilation of the small blood vessels has been observed in patients with cardiovascular disease, whereas in smokers, PYC prevents smoking-induced platelet aggregation and reduces the concentration of thromboxane. The ability to inhibit angiotensin-converting enzyme is associated with a mild antihypertensive effect. PYC relieves premenstrual symptoms, including abdominal pain and this action may be associated with the spasmolytic action of some phenolic acids. An improvement in cognitive function has been observed in controlled animal experiments and these findings support anecdotal reports of improvement in ADHD patients taking PYC supplements. CONCLUSIONS: There is much evidence showing that PYC has beneficial effects on physiological functions. Results from ongoing clinical research are required to confirm and extend previous observations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Shahidi, F., & Ambigaipalan, P. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.06.018 · Cited by 3,081
Natural phenolics in the prevention of UV-induced skin damage. A review
Svobodová, A., Psotová, J., & Walterová, D. (2003) · Biomedical Papers · doi:10.5507/bp.2003.019 · Cited by 455
Rasmussen, S. E., Frederiksen, H., Struntze Krogholm, K., & Poulsen, L. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400082 · Cited by 372
Natural and synthetic antioxidants: An updated overview
Augustyniak, A., Bartosz, G., Čipak, A., Duburs, G., Horáková, L., Łuczaj, W., Majekova, M., Odysseos, A. D., Rackova, L., Skrzydlewska, E., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.508495 · Cited by 319
Shui, G., & Leong, L. P. (2006) · Food Chemistry · doi:10.1016/j.foodchem.2005.03.048 · Cited by 272
Phytotherapy in diabetes: Review on potential mechanistic perspectives
El-Abhar, H. S., & Schaalan, M. F. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i2.176 · Cited by 145
Schäfer, A., & Högger, P. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.10.011 · Cited by 136
Liu, X., Wei, J., Tan, F., Zhou, S., Würthwein, G., & Rohdewald, P. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.10.043 · Cited by 124
Self-citationCho, H., Lee, M., Lee, J. W., No, K., Park, S., Lee, H., Kang, S., Cho, W., Park, H. J., Oh, K. W., et al. (2007) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2007.00298.x · Cited by 105
Unravelling the Biological Potential of Pinus pinaster Bark Extracts
Ferreira-Santos, P., Genisheva, Z., Botelho, C., Santos, J., Ramos, C., Teixeira, J. A., & Rocha, C. M. R. (2020) · Antioxidants · doi:10.3390/antiox9040334 · Cited by 104
Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans
NISHIOKA, K., HIDAKA, T., NAKAMURA, S., UMEMURA, T., JITSUIKI, D., SOGA, J., GOTO, C., CHAYAMA, K., YOSHIZUMI, M., & HIGASHI, Y. (2007) · Hypertension Research · doi:10.1291/hypres.30.775 · Cited by 85
Rhim, H. C., Kim, M. S., Park, Y.-J., Choi, W. S., Park, H. K., Kim, H. G., Kim, A., & Paick, S. H. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.12.002 · Cited by 57
Pycnogenol® supplementation improves health risk factors in subjects with metabolic syndrome
Belcaro, G., Cornelli, U., Luzzi, R., Cesarone, Dugall, M., Feragalli, B., Errichi, S., Ippolito, E., Grossi, M. G., Hosoi, M., et al. (2013) · Phytotherapy Research · doi:10.1002/ptr.4883 · Cited by 40
Pycnogenol® in Metabolic Syndrome and Related Disorders
Gulati, O. P. (2015) · Phytotherapy Research · doi:10.1002/ptr.5341 · Cited by 39
Weichmann, F., & Rohdewald, P. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1389374 · Cited by 38
Self-citationCong, H., Zhong, W., Wang, Y., Ikuyama, S., Fan, B., & Gu, J. (2018) · Journal of Diabetes Research · doi:10.1155/2018/9713259 · Cited by 9
“Pycnogenol (PYC), one of the natural antioxidants extracted from French maritime pine bark, is composed of procyanidins, phenolic acids, and bioflavonoids [14, 15].”
Background
Metadata
- Authors
- Rohdewald, P.
- Venue
- Int. Journal of Clinical Pharmacology and Therapeutics
- Publisher
- Dustri-Verlgag Dr. Karl Feistle
- Published
- 2002-04-01
- Volume
- 40
- Issue
- 04
- Pages
- 158-168
- ISSN
- 0946-1965 (ISSN-L)
- OpenAlex
- W1977698530
- Cited by
- 481
- References
- 0
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.